{
  "docId": "019de070-c935-736b-bfac-0e59550f8f0f",
  "docSlug": "bbdd6d1004c11d68b286eff6aee60dc0",
  "documentTitle": "argenx SE | Results Presentation Deck | 20 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 20,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "roadmap",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide outlines a multi-stage clinical trial process including a Go/No Go decision point.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-c935-736b-bfac-0e59550f8f0f/8",
  "deckHref": "/decks/019de070-c935-736b-bfac-0e59550f8f0f",
  "deckJsonHref": "/decks/019de070-c935-736b-bfac-0e59550f8f0f.json",
  "deckAnchorHref": "/decks/019de070-c935-736b-bfac-0e59550f8f0f#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.4,
        "y": 0.87
      },
      "kind": "callout",
      "text": "Go/No Go N=30",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2663a9be-b44f-48e1-a056-e9ba15e85caf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.8,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "diagram",
      "text": "Trial flow from screening to Stage B",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "93ed9428-2231-49ae-97f6-3e320bdbface",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.15,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "image",
      "text": "adhere logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "39704cac-1df9-4f30-aaf1-1e0136e0d621",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.14,
        "x": 0.84,
        "y": 0.32
      },
      "kind": "list",
      "text": "Efficacy analysis based on relapse (adjusted INCAT). Study endpoint with 88 relapse events in stage B. N=sample size estimation ~120-130. Followed by Open Label Extension study.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7e1c603a-c4bc-4b56-b2f2-658c6d0b7512",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.88,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Chronic Inflammatory Demyelinating Polyneuropathy: Phase 2/3 ADHERE Trial",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c28f5f84-fffd-414a-954a-6783717ead4a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "a9e6d02d-8e5a-4178-ba38-7f25d2be9e60",
      "evidence": "The slide maps out the phases and stages of a clinical trial (screening, run-in, treatment).",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 4,
      "beatId": "370e7a7b-342c-4314-a537-20aca17005f0",
      "arcName": "Rags to Riches",
      "arcSlug": "rags-to-riches",
      "beatName": "Rising Success",
      "beatSlug": "rags-to-riches-rising-success",
      "evidence": "The presentation highlights the company's promising pipeline and clinical trials",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 8,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "9f6093ef-7c49-4bf6-8291-96e05249086f",
      "evidence": "The presentation presents several clinical trials and pipeline opportunities",
      "position": 1,
      "objective": "Highlight the potential of efgartigimod in various indications",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}